5 Pharmaceutical preparations for treatment of diseases, disorders, and conditions associated with senescence; pharmaceutical preparations for treatment of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health